SCHEMBL14064702

SCHEMBL14064702

C=CCCCCCCCCOc1ccc(C[PH](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KCNA3 P22001 1/20 0.41
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
LSS P48449 2/20 0.38
HTT P42858 1/20 0.37
FFAR1 O14842 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7589130 0.82 LTA4H (0.46) L3MBTL1ALDH1A1KCNA3NPC1RAB9A
SCHEMBL14064709 0.81 LTA4H (0.57) ALDH1A1NPC1RAB9AHTTLTA4H
SCHEMBL13326468 0.81 LTA4H (0.57) ALDH1A1NPC1RAB9AHTTLTA4H
SCHEMBL13326469 0.81 LTA4H (0.57) ALDH1A1NPC1RAB9AHTTLTA4H
SCHEMBL13863192 0.81 LTA4H (0.57) ALDH1A1NPC1RAB9AHTTLTA4H
SCHEMBL14064708 0.81 LTA4H (0.57) ALDH1A1NPC1RAB9AHTTLTA4H
SCHEMBL9684375 0.80 KCNA3 (0.64) L3MBTL1ALDH1A1KCNA3KDM4EHDAC3
SCHEMBL18936005 0.80 KCNA3 (0.64) L3MBTL1ALDH1A1KCNA3KDM4EHDAC3
SCHEMBL31281844 0.80 KCNA3 (0.64) L3MBTL1ALDH1A1KCNA3KDM4EHDAC3
SCHEMBL5053411 0.80 KCNA3 (0.64) L3MBTL1ALDH1A1KCNA3KDM4EHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7422702-B2 Benzene derivative having long, linear conjugated structure, process for producing benzene derivative, and liquid-crystal material NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2008-09-09 US disclosed
US-7390433-B2 Benzene derivative having long, linear conjugated structure, process for producing benzene derivative, and liquid-crystal material NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2008-06-24 US disclosed
US-20070029520-A1 Benzene Derivative Having Long, Linear Conjugated Structure, Process For Producing Benzene Derivative, And Liquid-Crystal Material NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070029520-A1 Benzene Derivative Having Long, Linear Conjugated Structure, Process For Producing Benzene Derivative, And Liquid-Crystal Material ABCB11, SLC43A1, SLC43A3 L3MBTL1 1540/4885ALDH1A1 492/4885KCNA3 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.